期刊文献+

血液灌流联合血液滤过治疗脓毒性休克患者的临床疗效研究 被引量:11

Clinical effects of combination of hemoperfusion(HP) and continuous veno-venous hemofiltration(CVVH) in patients with septic shock
下载PDF
导出
摘要 目的研究血液灌流(hemoperfusion,HP)联合连续性静脉-静脉血液滤过治疗(continuous veno-venous he-mofiltration,CVVH)对脓毒性休克(septic shock)患者的临床疗效,探讨HP联合CVVH对脓毒性休克患者的治疗作用。方法采用随机、对照的方式,将我科2009年9月~2010年8月收的APACHEII评分≥15分的36例脓毒性休克患者,分为对照组(C组)、CVVH组(V组)、HP+CVVH组(H组),每组各12例,分别进行常规治疗、常规治疗+CVVH治疗、常规治疗+HP+CVVH治疗,比较各组28d存活率、SOFA评分、生命体征、血流动力学、肺部氧合及其它器官功能的变化。结果C组、V组、H组28d存活率分别为41.67%、58.33%、66.67%,有所提高,但3组间差异无统计学意义。与C组相比,V组从第4d起SOFA评分即明显降低(P<0.05),H组第2d起SOFA评分即明显降低(P<0.05)。与C组相比,V组从第4d起氧合指数即明显升高(P<0.05),H组第2d起氧合指数即明显升高(P<0.05),且在第2d、3d,H组较V组明显升高(P<0.05)。与C组相比,V组及H组血管活性药物使用时间、呼吸机使用时间明显缩短;增快的心率、血白细胞、高体温明显下降、酸中毒明显纠正(P<0.05);血糖、血乳酸、血肌肝、尿素氮、谷草转氨酶、胆红素均明显降低(P<0.05);但纤维蛋白原(Fib)、凝血酶原时间(PT)、血红蛋白(Hb)、血小板(PLT)均无明显变化(P>0.05)。结论 VVH及HP+CVVH治疗均能促进脓毒性休克患者器官功能恢复,且以HP+CVVH治疗效果更佳。HP+CVVH治疗对患者凝血系统无明显影响,不良反应小。 Objective To investigate the clinical effects of combination of hemoperfusion(HP) and continuous veno-venous hemofiltration(CVVH) in patients with septic shock.Methods 36 patients with septic shock and their acute physiology and chronic health evaluation II(APACHEII) 15,were randomly assigned to control group(C group)/Continuous veno-venous hemofiltration group(CVVH group)/hemoperfusion and Continuous veno-venous hemofiltration group(HP +CVVH group),with roution therapy /roution and CVVH therapy/roution and HP and CVVH therapy respectively.And the difference survival rate for 28 days,sepsis related organ failure assessment(SOFA),the vital sign,hemodynamic parameter,oxygenation index,and other organ functions were evaluated.Results 1.The 28d survival rate of the Group C,Group V and the Group H were 41.67%,58.33%,66.67%,but Differences among the groups were not statistically significant.2.The SOFA Score in Group V were lower than in group C from the fourth day on(P〈0.05).It was also lower in group H than group C from the second day on(P〈0.05).3.The oxygenation index was increased from the 4th day in group V compared with group C(P〈0.05).The oxygenation index in group H was higher than group C from the second day(P〈0.05),and was higher than group V in the second and third day(P〈0.05).4.As compared with group C,the time of breathing machine and vasoactive agent use was reduced in group H and group V,but no differences were seen between the two groups(P〈0.05).As compared with group C,the heart rate,the WBC,the body temperature was decreased,the PH value in group V was increased,the blood glucose,lactic acid,Cr,UN,AST,DB were all decreased(P〈0.05),and the Fib,PT,Hb,PLT were not statistically significant(P〈0.05),in group H and group V.Conclusion Both the CVVH and the HP+CVVH can promote the recovery of organ function,and the HP+CVVH may has better effects.3.The HP+CVVH doesn't influence the function of blood coagulation,which indicating there are no significant adverse effects involved.
出处 《四川医学》 CAS 2012年第7期1135-1138,共4页 Sichuan Medical Journal
基金 第三军医大学西南医院院管课题(编号:2008XG19)
关键词 血液灌流 血液滤过 脓毒性休克 细胞因子 预后 clinical effects hemoperfusion continuous venous-venous hemofihration septic shock
  • 相关文献

参考文献7

  • 1Bone RC,Balk RA,Cerra FB,et al.The ACCP/SCCM consensus conference committee.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest,1992,101(6):1644.
  • 2De Vriese AS,Colardyn FA,Philppe JJ,et al.Cytokine removal during continuous hemofiltration in sepsis patoents[J].J Am Sol Nephrol,1999,10:846-853.
  • 3谢红浪,季大玺,龚德华,汪义军,黎磊石.连续性肾脏替代治疗对外周血细胞因子的影响[J].肾脏病与透析肾移植杂志,1999,8(3):217-219. 被引量:81
  • 4Lonnemann G,Bechatein M,Linnenweber S,et al.Tumor necrosis facror-alpha during continuous high-flux hemodialysis in sepsis with a-cute renal failure[J].Kidney Int Suppl,1999,(72):84 -87.
  • 5何盛琴,熊建琼,屈纪富,张雷,王涛,张永辉,张彦,陈琨.血液净化对脓毒性休克患者血清细胞因子及预后的影响[J].第三军医大学学报,2011,33(10):1061-1064. 被引量:27
  • 6Levy MM,Fink MP,Marshall }C,et al.2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definition Conference[J].Crit Care Med,2003,31(4)-1250-1256.
  • 7Bagshaw SM,Berthiaume LR.Delaney A,et al.Continuous versus intermittent renal replacement therapy for critically ill patient with acute kidney injury:a meta-analysis[J].Crit Care Med,2008,36(2):610-617.

二级参考文献17

  • 1余晨,刘志红,陈朝红,龚德华,季大玺,黎磊石.连续性血液净化对血浆细胞因子水平的影响及其清除机制[J].肾脏病与透析肾移植杂志,2004,13(5):401-407. 被引量:68
  • 2孟新科,郑晓英,吴华雄,杨径,魏刚,陈伟峰,刘德红.急性生理学与慢性健康状况Ⅱ评分在连续性血液净化治疗多器官功能障碍综合征中的应用[J].中国危重病急救医学,2005,17(5):313-314. 被引量:8
  • 3季大玺 谢红浪 等.连续性肾脏替代治疗在重症急性肾功能衰竭中救治中的应用[J].肾脏病与透析肾移植杂志,1997,6:415-415.
  • 4Lonnemann G, Bechstein M, Linnenweber S, et al. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure[J]. Kidney Int Suppl, 1999, (72) : S84 -S87.
  • 5De-Vriese A S, Colardyn F A, Philippe J J, et al. Cytokine removal during continuous hemofittration in septic patients[ J]. J Am Soc Nephrol, 1999, 10(4): 846-853.
  • 6Levy M M, Fink M P, Marshall J C, et al. 2001 SCCM/ESICM/AC- CP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Me.d, 2003, 31(4) : 1250-1256.
  • 7Bone R C. Immunologic dissonance: a continuing evolution in our un- derstanding of the systemic inflammatory response syndrome ( SIRS ) and the multiple organ dysfunction syndrome ( MODS ) [ J ]. Ann Inter Med, 1996, 125(8) : 680 -687.
  • 8Lenz A, Franklin G A, Cheadle W G. Systemic inflammation after trauma[ J]. Injury, 2007, 38 (12) : 1336 - 1345.
  • 9Tsuchida K, Yoshimura R, Nakatani T, et al. Blood purification for critical illness : eytokines adsorption therapy [J]. Ther Apher Dial, 2006, 10(1) : 25 -31.
  • 10Koch T. Origin and mediators involved in sepsis and the systemic inflammatory response syndrome[J]. Kidney Int Suppl, 1998, 64:S66 -S69.

共引文献105

同被引文献72

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部